Loading Events

Human Tissue Solutions for New Medicines and Companion Diagnostics

18 March 2010

  • This event has passed.


18 March 2010

Human Tissue Solutions for New Medicines and Companion Diagnostics at Granta Park, Great Abingdon, Cambridge

Sponsors: Asterand & HealthTech & Medicines KTN

Organised by: Pathology Diagnostics Ltd

This workshop is an update on the critical factors to success in using human tissues to develop novel therapeutics and clinical diagnostics.

The workshop will cover the following areas:
practical and regulatory issues relating to the acquisition of human tissues in the UK; the use of human tissue based assays in the drug and biomarker development process; plus the practicalities and requirements of bringing such assays into the clinic as diagnostic tests. The seminar brings together specialists from drug discovery to the clinic, and concludes with a panel discussion.

Presentations will include:

  • The Ethics and Governance Environment for using Human Tissues for Research in the UK
  • Practical considerations in securing a supply of human tissue for research
  • Integrating Candidate Predictive Biomarkers into Oncology Drug Development
  • The Role of Immunohistochemistry in a Biomarker Development Pipeline
  • The development of monoclonal antibodies for use in Immunohistochemistry as clinical diagnostics
  • Evaluation of new health technologies – companion diagnostics – in the context of the NHS

    Speakers include:

  • Dr Brian Clark, CEO onCore UK
  • Professor Chris Womack, Manchester Cancer Research Centre Biobank; AstraZeneca UK
  • Dr. Darren Hodgson, Biomics Advisor, Clinical Biomarker Group, AstraZeneca UK.
  • Dr. Will Howat, Head of the Histopathology/ISH Cambridge Research Institute, CRUK
  • Dr. Gary McIntosh, Head of R& D, Novocastra Antibodies/Leica Microsystems, UK

    Who should attend:
    The workshop is for academic and industry scientists, clinicians and allied healthcare staff, individuals involved in the collection storage and supply of human tissues for research, plus investors in translational medicine and drug and companion diagnostic development. You will be working in the following organisations:

  • Major pharma, biotech and other companies working on advanced therapy medicinal products
  • Companies supplying/developing companion diagnostics, including major pharma, biotech and CROs
  • Acadamic scientists working in translational medicine
  • NHS and other healthcare organisations
  • Investors and technology transfer specialists
  • Registration fees:

    ERBI gold member: 3 delegates free; £40 + VAT pp subsequently
    ERBI silver member: 1 delegate free; £40 + VAT pp subsequently
    Non ERBI members: industry: £150 + VAT
    academics/NHS staff – free

    For the full agenda visit

    If you would like to attend this meeting, please email: email.

    Conference organisers: Dr. Madhuri Warren, Pathology Diagnostics Ltd., Cambridge UK
    Barnaby Perks, ERBI, Cambridge, UK